This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $9,922.36 fixed-price delivery order is for the supply of 4 milligram Ondansetron hydrochloride tablets, with a period of performance through November 15, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical goods for military personnel, veterans, and other federal beneficiaries.
The contract award was not designated with any set-aside requirements, indicating open competition. No subcontractors were mentioned in the provided information.
Generated 2/13/25, 9:12 AM